Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005
Published online before print May 12, 2005, doi: 10.1161/01.RES.0000170084.88780.ea
A more recent version of this article appeared on June 10, 2005
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/11/1152    most recent
01.RES.0000170084.88780.eav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rolli-Derkinderen, M.
Right arrow Articles by Pacaud, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rolli-Derkinderen, M.
Right arrow Articles by Pacaud, P.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*L-SERINE
*NITRIC OXIDE
Related Collections
Right arrow Cell signalling/signal transduction
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

Submitted on February 16, 2005
Revised on May 4, 2005
Accepted on May 4, 2005

Phosphorylation of Serine 188 Protects RhoA from Ubiquitin/Proteasome-Mediated Degradation in Vascular Smooth Muscle Cells

Malvyne Rolli-Derkinderen ; Vincent Sauzeau ; Laurent Boyer ; Emmanuel Lemichez ; Céline Baron ; Daniel Henrion ; Gervaise Loirand ; and Pierre Pacaud *

From INSERM U-533 (M.R.-D., V.S., G.L., P.P.), Faculté des Sciences, Nantes, INSERM U-627 (L.B., E.L.), Faculté de Médecine, Nice and CNRS UMR 6188 (C.B., D.H.), Faculté de Médecine, Angers, France

* To whom correspondence should be addressed. E-mail: pierre.pacaud{at}univ-nantes.fr.

cAMP and cyclic GMP-dependent kinases phosphorylate the small G protein RhoA on Ser188. We have previously demonstrated that phosphorylation of Ser188 inhibits RhoA-dependent functions and positively regulates RhoA expression, and that the nitric oxide (NO)/cGMP-dependent protein kinase (PKG) pathway plays an essential role, both in vitro and in vivo, in the regulation of RhoA protein expression and functions in vascular smooth muscle cells. Here we analyze the consequences of Ser188 phosphorylation on RhoA protein degradation. By expressing Ser188 phosphomimetic wild-type (WT-RhoA-S188E) and active RhoA proteins (Q63L-RhoA-S188E), we show that phosphorylation of Ser188 of RhoA protects RhoA, particularly its active form, from ubiquitin-mediated proteasomal degradation. Coimmunoprecipitation experiments indicate that the resistance of the phosphorylated active form of RhoA to proteasome-mediated degradation is due to its cytoplasmic sequestration through enhanced RhoGDI interaction. In rat aortic smooth muscle cells, stimulation of PKG and inhibition of proteasome by lactacystin induce nonadditive increases in RhoA protein expression. In addition, stimulation of PKG leads to the accumulation of GTP-bound RhoA in the cytoplasm. In vivo stimulation of the NO/PKG signaling by treating rats with sildenafil increased RhoA level and RhoA phosphorylation, and enhanced its association to RhoGDI in the pulmonary artery, whereas opposite effects are induced by chronic inhibition of NO synthesis in N-{omega} -nitro-L-arginine-treated rats. Our results thus suggest that Ser188 phosphorylation-mediated protection against degradation is a physiological process regulating the level of endogenous RhoA and define a novel function for RhoGDI, as an inhibitor of Rho protein degradation.


Key words: Rho-GTP-binding proteins • signal transduction • phosphorylation • cGMP • Ubiquitin




This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
N. Sawada, H. Itoh, K. Miyashita, H. Tsujimoto, M. Sone, K. Yamahara, Z. P. Arany, F. Hofmann, and K. Nakao
Cyclic GMP Kinase and RhoA Ser188 Phosphorylation Integrate Pro- and Antifibrotic Signals in Blood Vessels
Mol. Cell. Biol., November 15, 2009; 29(22): 6018 - 6032.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Cushman and P. J. Casey
Role of Isoprenylcysteine Carboxylmethyltransferase-catalyzed Methylation in Rho Function and Migration
J. Biol. Chem., October 9, 2009; 284(41): 27964 - 27973.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
L. S Kirschner, Z. Yin, G. N Jones, and E. Mahoney
Mouse models of altered protein kinase A signaling
Endocr. Relat. Cancer, September 1, 2009; 16(3): 773 - 793.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
E.J. Belin de Chantemele, K. Retailleau, F. Pinaud, E. Vessieres, A. Bocquet, A.L. Guihot, B. Lemaire, V. Domenga, C. Baufreton, L. Loufrani, et al.
Notch3 Is a Major Regulator of Vascular Tone in Cerebral and Tail Resistance Arteries
Arterioscler Thromb Vasc Biol, December 1, 2008; 28(12): 2216 - 2224.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
P. Weinmeister, R. Lukowski, S. Linder, C. Traidl-Hoffmann, L. Hengst, F. Hofmann, and R. Feil
Cyclic Guanosine Monophosphate-dependent Protein Kinase I Promotes Adhesion of Primary Vascular Smooth Muscle Cells
Mol. Biol. Cell, October 1, 2008; 19(10): 4434 - 4441.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. T. G. Ho, S. D. Merajver, C. M. Lapiere, B. V. Nusgens, and C. F. Deroanne
RhoA-GDP Regulates RhoB Protein Stability: POTENTIAL INVOLVEMENT OF RhoGDI{alpha}
J. Biol. Chem., August 1, 2008; 283(31): 21588 - 21598.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod
Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats
Cardiovasc Res, July 15, 2008; 79(2): 322 - 330.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Guilluy, M. Rolli-Derkinderen, L. Loufrani, A. Bourge, D. Henrion, L. Sabourin, G. Loirand, and P. Pacaud
Ste20-Related Kinase SLK Phosphorylates Ser188 of RhoA to Induce Vasodilation in Response to Angiotensin II Type 2 Receptor Activation
Circ. Res., May 23, 2008; 102(10): 1265 - 1274.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. H. Psahoulia, S. Moumtzi, M. L. Roberts, T. Sasazuki, S. Shirasawa, and A. Pintzas
Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells
Carcinogenesis, May 1, 2007; 28(5): 1021 - 1031.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
B. Wojciak-Stothard, B. Torondel, L. Y. F. Tsang, I. Fleming, B. Fisslthaler, J. M. Leiper, and P. Vallance
The ADMA/DDAH pathway is a critical regulator of endothelial cell motility
J. Cell Sci., March 15, 2007; 120(6): 929 - 942.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Guilluy, M. Rolli-Derkinderen, P.-L. Tharaux, G. Melino, P. Pacaud, and G. Loirand
Transglutaminase-dependent RhoA Activation and Depletion by Serotonin in Vascular Smooth Muscle Cells
J. Biol. Chem., February 2, 2007; 282(5): 2918 - 2928.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Q. Pan, L. W. Bao, T. N. Teknos, and S. D. Merajver
Targeted Disruption of Protein Kinase C{varepsilon} Reduces Cell Invasion and Motility through Inactivation of RhoA and RhoC GTPases in Head and Neck Squamous Cell Carcinoma
Cancer Res., October 1, 2006; 66(19): 9379 - 9384.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Z. Xie, W. Su, Z. Guo, H. Pang, S. R. Post, and M. C. Gong
Up-regulation of CPI-17 phosphorylation in diabetic vasculature and high glucose cultured vascular smooth muscle cells
Cardiovasc Res, February 1, 2006; 69(2): 491 - 501.
[Abstract] [Full Text] [PDF]